MX2019000201A - Uso de co-polimero bi-funcional para aplicaciones oftalmicas y otras aplicaciones topicas y locales. - Google Patents

Uso de co-polimero bi-funcional para aplicaciones oftalmicas y otras aplicaciones topicas y locales.

Info

Publication number
MX2019000201A
MX2019000201A MX2019000201A MX2019000201A MX2019000201A MX 2019000201 A MX2019000201 A MX 2019000201A MX 2019000201 A MX2019000201 A MX 2019000201A MX 2019000201 A MX2019000201 A MX 2019000201A MX 2019000201 A MX2019000201 A MX 2019000201A
Authority
MX
Mexico
Prior art keywords
ophthalmic
topical
functional
methods
contact lens
Prior art date
Application number
MX2019000201A
Other languages
English (en)
Inventor
Rex Cooper Eugene
Maxwell Kleinman David
Loxley Andrew
Mitchnick Mark
Original Assignee
Eyeon Particle Sciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eyeon Particle Sciences Llc filed Critical Eyeon Particle Sciences Llc
Publication of MX2019000201A publication Critical patent/MX2019000201A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Graft Or Block Polymers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención contempla un copolímero que es un copolímero de injerto o de bloque útil para cambiar la temperatura de la superficie ocular y otras características de superficies biológicas o de lente de contacto o. Métodos para el uso de estas formulaciones y recubrimientos para incrementar la temperatura de la piel, membranas mucosas, ojo, o párpados ayudará a tratar muchas afecciones que incluyen blefaritis y úlceras no curativas. Se proporcionan métodos para disminuir la evaporación, mejorar la humectabilidad y estabilizar la película lagrimal, y lubricar las superficies biológicas en un sujeto, por ejemplo, en el tratamiento de síndrome del ojo seco, y para mejorar la tolerabilidad de lentes de contacto.
MX2019000201A 2016-07-06 2016-07-06 Uso de co-polimero bi-funcional para aplicaciones oftalmicas y otras aplicaciones topicas y locales. MX2019000201A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/041079 WO2018009177A1 (en) 2016-07-06 2016-07-06 Bi-functional co-polymer use for ophthalmic and other topical and local applications

Publications (1)

Publication Number Publication Date
MX2019000201A true MX2019000201A (es) 2019-06-20

Family

ID=60913016

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019000201A MX2019000201A (es) 2016-07-06 2016-07-06 Uso de co-polimero bi-funcional para aplicaciones oftalmicas y otras aplicaciones topicas y locales.

Country Status (5)

Country Link
US (2) US11135242B2 (es)
AU (1) AU2016413933B2 (es)
CA (1) CA3029391C (es)
MX (1) MX2019000201A (es)
WO (1) WO2018009177A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023081891A2 (en) * 2021-11-05 2023-05-11 Calm Water Therapeutics Llc Methods for using bioadhesive and steric interactions of copolymers with at least two moieties to minimize adverse effects mediated by external influences on cell, tissue, organ system, and organism biology

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB533195A (en) 1938-10-20 1941-02-07 Philips Nv Improvements in or relating to the manufacture of wire provided with lacquer insulation
GB722470A (en) 1952-09-01 1955-01-26 Vickers Electrical Co Ltd Improvements in and relating to dynamo electric machines
GB1009451A (en) 1961-07-11 1965-11-10 Handelsvereeniging V H W Van D Washing machine
FR1449627A (fr) 1965-03-06 1966-05-06 Sarl Balcar Dispositif d'éclairage à usages multiples
US5607698A (en) 1988-08-04 1997-03-04 Ciba-Geigy Corporation Method of preserving ophthalmic solution and compositions therefor
US5232984A (en) 1990-10-15 1993-08-03 The Board Of The Regents The University Of Texas Biocompatible microcapsules
US5462990A (en) 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US5380536A (en) 1990-10-15 1995-01-10 The Board Of Regents, The University Of Texas System Biocompatible microcapsules
WO1998047948A1 (en) 1997-04-18 1998-10-29 California Institute Of Technology Multifunctional polymeric tissue coatings
EP1009451B1 (en) 1997-08-27 2003-10-29 California Institute Of Technology Compositions and their use to prevent formation of adhesions in biological tissues
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
DE69921158T2 (de) 1998-08-27 2006-01-12 Eidgenössische Technische Hochschule Zürich Gele und mehrschichtige oberflächenstrukturen aus boronsäurehaltigen polymeren
US6037328A (en) 1998-12-22 2000-03-14 Bausch & Lomb Incorporated Method and composition for rewetting and preventing deposits on contact lens
US6703039B2 (en) * 2000-12-06 2004-03-09 Bausch & Lomb Incorporated Reversible gelling system for ocular drug delivery
CN102178692A (zh) 2002-07-03 2011-09-14 派瑞克科学公司 透明质酸组合物以及使用方法
US6732521B2 (en) 2002-08-16 2004-05-11 Toyota Jidosha Kabushiki Kaisha Control system for a turbo-charged diesel aircraft engine
KR100592512B1 (ko) * 2002-11-22 2006-07-03 서울약품공업(주) 탐술로신 또는 약제학적으로 허용되는 이의 염을활성성분으로 하는 서방성 배뇨장애 치료제
ATE471723T1 (de) 2003-05-15 2010-07-15 Menicon Co Ltd Zusammensetzung zur ophthalmischen verwendung
US20050202097A1 (en) 2004-03-12 2005-09-15 Melbj Holdings, Llc, Florida Lubricant for the ocular surface
US7247692B2 (en) 2004-09-30 2007-07-24 Johnson & Johnson Vision Care, Inc. Biomedical devices containing amphiphilic block copolymers
WO2006044660A2 (en) 2004-10-14 2006-04-27 Vanderbilt University Functionalized solid lipid nanoparticles and methods of making and using same
US20060153926A1 (en) * 2005-01-10 2006-07-13 Bascom Charles C Compositions, products and methods for controlling weight in a mammal
CN100352508C (zh) 2005-01-17 2007-12-05 涂家生 一种眼用嵌段聚合物
AU2006210954A1 (en) 2005-01-31 2006-08-10 Merck & Co., Inc. Antidiabetic bicyclic compounds
US20070203039A1 (en) 2005-12-21 2007-08-30 Roya Borazjani Method for cleaning and maintaining contact lenses and related system and kit
US7811555B2 (en) 2005-12-30 2010-10-12 Cordis Corporation Tri-branched biologically active copolymer
US20090011040A1 (en) 2007-05-02 2009-01-08 Naash Muna I Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases
ITMI20080003A1 (it) 2008-01-02 2009-07-03 Alfredo Pulpito Composizioni per uso oftalmico
US8802075B2 (en) 2009-02-18 2014-08-12 Eyeon Particle Sciences Llc Bi-functional co-polymer use for opthalmic and other topical and local applications
US20190159929A1 (en) * 2017-11-29 2019-05-30 Bruder Healthcare Company, Llc Moist heat delivery therapy device with a multi-layer laminate structure

Also Published As

Publication number Publication date
AU2016413933B2 (en) 2023-06-15
US20220023334A1 (en) 2022-01-27
AU2016413933A1 (en) 2019-04-11
US20190134079A1 (en) 2019-05-09
CA3029391C (en) 2024-01-02
WO2018009177A1 (en) 2018-01-11
CA3029391A1 (en) 2018-01-11
US11135242B2 (en) 2021-10-05

Similar Documents

Publication Publication Date Title
PH12019000194A1 (en) Opthamic lens comprising lenslets for preventing and/or slowing myopia progression
MX361506B (es) Lente de contacto que comprende lentículo no coaxial para prevenir y/o reducir la velocidad de la progresión de la miopía.
BR112019007405A2 (pt) lágrima artificial, lente de contato e composições de veículos de fármacos e métodos de utilização dos mesmos
RU2015134858A (ru) Конфигурация линзы, не зависящей от размера зрачка, и способ для предотвращения и/или замедления прогрессирования миопии
WO2016183424A8 (en) Light adjustable intraocular lenses using upconverting nanoparticles and near infrared (nir) light
MX2011013060A (es) Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas.
WO2016029191A3 (en) Channel modulators
MX2009012645A (es) Formulaciones y metodos para tratar el ojo seco.
EP3154413A4 (en) Surface treatment of contact lens and treatment of ocular discomfort by water soluble polymers and lipids/liposomes
NZ746468A (en) Methods of treating ocular conditions
MY196448A (en) Anti-Htra1 Antibodies and Methods of use Thereof
WO2017156460A8 (en) Synthetic polymeric implantable artificial cornea device incorporating nanopatterns
CL2016002827A1 (es) Sistema para limpiar una región ocular, que comprende a un aplicardor que consiste de una primera y segunda camara, un elemento sellable que divide la primera y segunda camara, donde la segunda camara contiene una composicion ocular y b un surtidor kit y metodos de tratamientos.
BR112017015387A2 (pt) composição em gel tópica, método de tratamento de uma infecção da pele, composição em gel oftálmica, e, método de tratamento de uma afecção infecciosa do olho ou pálpebra
EP4279063A3 (en) Ophthalmic pharmaceutical composition, preparation method therefor and application thereof
CY1124538T1 (el) Χρηση prg4 για τη βελτιωση της δυναμικης οπτικης οξυτητας και εκτροπων υψηλοτερης ταξης
EP3737431A4 (en) METHODS, POLYMER-CONTAINING FORMULATIONS AND POLYMER COMPOSITIONS FOR TREATMENT OF RETAIN DETECTION AND OTHER EYE DISEASES
EP3765095A4 (en) OPHTHALMIC COMPOSITIONS OF INDIGO-CARMINE AND EYEPIECES USES THEREOF
EA035539B9 (ru) Офтальмологическая композиция для применения при лечении офтальмологических расстройств, связанных с изменениями роговично-конъюнктивальной поверхности
MX2019000201A (es) Uso de co-polimero bi-funcional para aplicaciones oftalmicas y otras aplicaciones topicas y locales.
TN2019000112A1 (en) Ophthalmic formulation comprising citicoline carried by liposome for the treatment of glaucoma
WO2016016518A3 (fr) Dérivés de stérols pour le traitement de la perte auditive neurosensorielle et composition correspondante
EP3758693A4 (en) USE OF (1S, 3S) -3-AMINO-4- (DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND (S) -3-AMINO-4- (DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1 -CARBOXYLIC IN THE TREATMENT OF EYE DISORDERS
SG11201806918QA (en) Anti-acanthamoeba contact lens solution
WO2014117010A3 (en) Composition for ophthalmic administration